
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Aegerion Pharmaceuticals was acquired by Amryt Pharma plc 24 September 2019. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline. Please Follow us at https://www.linkedin.com/company/amryt-pharma-plc
Rare disease,biotech,and global
Aegerion pharmaceuticals operates in the Biotechnology research industry.
Aegerion pharmaceuticals's revenue is 11m - 100m
Aegerion pharmaceuticals has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.